Cite
HARVARD Citation
Rekić, D. et al. (2022). AZD8233 antisense oligonucleotide targeting PCSK9 does not prolong QT interval. British journal of clinical pharmacology. 88 (11), pp. 4839-4844. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rekić, D. et al. (2022). AZD8233 antisense oligonucleotide targeting PCSK9 does not prolong QT interval. British journal of clinical pharmacology. 88 (11), pp. 4839-4844. [Online].